269 related articles for article (PubMed ID: 19761413)
1. GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology.
Tur-Kaspa I; Ezcurra D
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1323-36. PubMed ID: 19761413
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization.
Hsieh YY; Chang CC; Tsai HD
Taiwan J Obstet Gynecol; 2008 Mar; 47(1):66-74. PubMed ID: 18400585
[TBL] [Abstract][Full Text] [Related]
3. Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study.
Bahçeci M; Ulug U; Ben-Shlomo I; Erden HF; Akman MA
J Reprod Med; 2005 Feb; 50(2):84-90. PubMed ID: 15755044
[TBL] [Abstract][Full Text] [Related]
4. Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.
Hwang JL; Seow KM; Lin YH; Huang LW; Hsieh BC; Tsai YL; Wu GJ; Huang SC; Chen CY; Chen PH; Tzeng CR
Hum Reprod; 2004 Sep; 19(9):1993-2000. PubMed ID: 15284212
[TBL] [Abstract][Full Text] [Related]
5. Gonadotrophin-releasing hormone antagonists for assisted conception.
Al-Inany H; Aboulghar M
Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
[TBL] [Abstract][Full Text] [Related]
6. The role of gonadotropin-releasing hormone antagonists in in vitro fertilization.
Diedrich K; Ludwig M; Felberbaum RE
Semin Reprod Med; 2001 Sep; 19(3):213-20. PubMed ID: 11679902
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents?
Griesinger G; Felberbaum RE; Schultze-Mosgau A; Diedrich K
Drugs; 2004; 64(6):563-75. PubMed ID: 15018588
[TBL] [Abstract][Full Text] [Related]
8. [GnRH antagonist (Orgalutran) for prevention of premature LH surges during controlled ovarian hyperstimulation].
Vladimirov Ia
Akush Ginekol (Sofiia); 2001; 40(4):21-6. PubMed ID: 11803865
[TBL] [Abstract][Full Text] [Related]
9. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients.
Hosseini MA; Aleyasin A; Saeedi H; Mahdavi A
J Obstet Gynaecol Res; 2010 Jun; 36(3):605-10. PubMed ID: 20598044
[TBL] [Abstract][Full Text] [Related]
10. [Use of GnRH antagonists (cetrorelix) in assisted reproduction: first report in Mexican literature].
Kably Ambe A; Ruiz AJ; Baptista AA; Serulle Y; Quesnel BC
Ginecol Obstet Mex; 2002 Sep; 70():424-30. PubMed ID: 12448050
[TBL] [Abstract][Full Text] [Related]
11. Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study.
Pelinck MJ; Vogel NE; Hoek A; Arts EG; Simons AH; Heineman MJ
Hum Reprod; 2005 Mar; 20(3):642-8. PubMed ID: 15608031
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial.
Lee TH; Lin YH; Seow KM; Hwang JL; Tzeng CR; Yang YS
Fertil Steril; 2008 Jul; 90(1):113-20. PubMed ID: 18054932
[TBL] [Abstract][Full Text] [Related]
13. Impact of coasting in patients undergoing controlled ovarian stimulation with the gonadotropin-releasing hormone antagonist cetrorelix.
Bahceci M; Ulug U; Tosun S; Erden HF; Bayazit N
Fertil Steril; 2006 May; 85(5):1523-5. PubMed ID: 16566935
[TBL] [Abstract][Full Text] [Related]
14. Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration.
Lee TH; Wu MY; Chen HF; Chen MJ; Ho HN; Yang YS
Fertil Steril; 2005 Jun; 83(6):1700-7. PubMed ID: 15950639
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of GnRH agonists and antagonists in an ovular donation program].
Saucedo de la Llata E; Moraga Sánchez MR; Batiza Reséndiz V; Santos Haliscak R; Galache Vega P; Hernández Ayup S
Ginecol Obstet Mex; 2004 Feb; 72():53-6. PubMed ID: 15216901
[TBL] [Abstract][Full Text] [Related]
16. Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study.
Olivennes F; Fanchin R; Bouchard P; Taïeb J; Selva J; Frydman R
Hum Reprod; 1995 Jun; 10(6):1382-6. PubMed ID: 7593501
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation.
Albano C; Smitz J; Camus M; Riethmüller-Winzen H; Van Steirteghem A; Devroey P
Fertil Steril; 1997 May; 67(5):917-22. PubMed ID: 9130900
[TBL] [Abstract][Full Text] [Related]
18. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
[TBL] [Abstract][Full Text] [Related]
19. Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment.
Roulier R; Chabert-Orsini V; Sitri MC; Barry B; Terriou P
Reprod Biomed Online; 2003 Sep; 7(2):185-9. PubMed ID: 14567887
[TBL] [Abstract][Full Text] [Related]
20. Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol.
Griesinger G; Dawson A; Schultze-Mosgau A; Finas D; Diedrich K; Felberbaum R
Fertil Steril; 2006 Mar; 85(3):791-3. PubMed ID: 16500366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
